These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The current status of recombinant human factor VIII. Aronson DL Semin Hematol; 1991 Apr; 28(2 Suppl 1):55-6. PubMed ID: 1908131 [No Abstract] [Full Text] [Related]
7. Modern treatment of hemophilia: from the shadows towards the light. Mannucci PM Thromb Haemost; 1993 Jul; 70(1):17-23. PubMed ID: 8236096 [No Abstract] [Full Text] [Related]
9. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia. White GC; McMillan CW; Kingdon HS; Shoemaker CB N Engl J Med; 1989 Jan; 320(3):166-70. PubMed ID: 2492083 [No Abstract] [Full Text] [Related]
10. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies. Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234 [No Abstract] [Full Text] [Related]
11. The need for recombinant factor VIII: historical background and rationale. Hilgartner MW Semin Hematol; 1991 Apr; 28(2 Suppl 1):6-9. PubMed ID: 1908132 [No Abstract] [Full Text] [Related]
13. Recombinant factor VIII in hemophilia. Cohen A; Butler R N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552 [No Abstract] [Full Text] [Related]
14. Recombinant factor VIII in hemophilia A: the Canadian experience. Blanchette VS Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535 [TBL] [Abstract][Full Text] [Related]
15. Treatment of single factor deficiencies: a case study approach. Marques MB Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193 [No Abstract] [Full Text] [Related]
16. Factor VIII inhibitor and severity of hemophilia. Schoppmann A; Waytes AT Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549 [No Abstract] [Full Text] [Related]
17. Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group. Walker I; Poon MC Lancet; 1992 Jan; 339(8784):61-2. PubMed ID: 1345984 [No Abstract] [Full Text] [Related]
18. Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better. Franchini M Blood Transfus; 2010 Oct; 8(4):292-6. PubMed ID: 20967172 [No Abstract] [Full Text] [Related]
19. Recombinant antihemophilic factor. Med Lett Drugs Ther; 1993 Jun; 35(898):51-2. PubMed ID: 8497206 [No Abstract] [Full Text] [Related]
20. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Hedner U Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747 [No Abstract] [Full Text] [Related] [Next] [New Search]